1-6 of 6
Kensuke Tateishi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Intraoperative Integrated Diagnostic System for Malignant Central Nervous System Tumors

Takahiro Hayashi, Kensuke Tateishi, Shinichiro Matsuyama, Hiromichi Iwashita, Yohei Miyake, Akito Oshima, Hirokuni Honma, Jo Sasame, Katsuhiro Takabayashi, Kyoka Sugino, Emi Hirata, Naoko Udaka, Yuko Matsushita, Ikuma Kato, Hiroaki Hayashi, Taishi Nakamura, Naoki Ikegaya, Yutaro Takayama, Masaki Sonoda, Chihiro Oka, Mitsuru Sato, Masataka Isoda, Miyui Kato, Kaho Uchiyama, Tamon Tanaka, Toshiki Muramatsu, Shigeta Miyake, Ryosuke Suzuki, Mutsumi Takadera, Junya Tatezuki, Junichi Ayabe, Jun Suenaga, Shigeo Matsunaga, Kosuke Miyahara, Hiroshi Manaka, Hidetoshi Murata, Takaakira Yokoyama, Yoshihide Tanaka, Takashi Shuto, Koichi Ichimura, Shingo Kato, Shoji Yamanaka, Daniel P. Cahill, Satoshi Fujii, Ganesh M. Shankar, Tetsuya Yamamoto
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (1): 116–126.
https://doi.org/10.1158/1078-0432.CCR-23-1660
Published: 05 January 2024
View article titled, Intraoperative Integrated Diagnostic System for Malignant Central Nervous System Tumors
Open the PDF for Intraoperative Integrated Diagnostic System for Malignant Central Nervous System Tumors in another window
Includes: Supplementary data
Journal Articles

HSP90 Inhibition Overcomes Resistance to Molecular Targeted Therapy in BRAFV600E-mutant High-grade Glioma

Jo Sasame, Naoki Ikegaya, Masahito Kawazu, Manabu Natsumeda, Takahiro Hayashi, Masataka Isoda, Kaishi Satomi, Arata Tomiyama, Akito Oshima, Hirokuni Honma, Yohei Miyake, Katsuhiro Takabayashi, Taishi Nakamura, Toshihide Ueno, Yuko Matsushita, Hiromichi Iwashita, Yu Kanemaru, Hidetoshi Murata, Akihide Ryo, Keita Terashima, Shoji Yamanaka, Yukihiko Fujii, Hiroyuki Mano, Takashi Komori, Koichi Ichimura, Daniel P. Cahill, Hiroaki Wakimoto, Tetsuya Yamamoto, Kensuke Tateishi
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (11): 2425–2439.
https://doi.org/10.1158/1078-0432.CCR-21-3622
Published: 01 June 2022
View article titled, HSP90 Inhibition Overcomes Resistance to Molecular Targeted Therapy in <em>BRAF<sup>V600E</sup></em>-mutant High-grade Glioma
Open the PDF for HSP90 Inhibition Overcomes Resistance to Molecular Targeted Therapy in <em>BRAF<sup>V600E</sup></em>-mutant High-grade Glioma in another window
Includes: Supplementary data
Journal Articles

PI3K/AKT/mTOR Pathway Alterations Promote Malignant Progression and Xenograft Formation in Oligodendroglial Tumors

Kensuke Tateishi, Taishi Nakamura, Tareq A. Juratli, Erik A. Williams, Yuko Matsushita, Shigeta Miyake, Mayuko Nishi, Julie J. Miller, Shilpa S. Tummala, Alexandria L. Fink, Nina Lelic, Mara V.A. Koerner, Yohei Miyake, Jo Sasame, Kenji Fujimoto, Takahiro Tanaka, Ryogo Minamimoto, Shigeo Matsunaga, Shigeo Mukaihara, Takashi Shuto, Hiroki Taguchi, Naoko Udaka, Hidetoshi Murata, Akihide Ryo, Shoji Yamanaka, William T. Curry, Dora Dias-Santagata, Tetsuya Yamamoto, Koichi Ichimura, Tracy T. Batchelor, Andrew S. Chi, A. John Iafrate, Hiroaki Wakimoto, Daniel P. Cahill
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (14): 4375–4387.
https://doi.org/10.1158/1078-0432.CCR-18-4144
Published: 15 July 2019
View article titled, PI3K/AKT/mTOR Pathway Alterations Promote Malignant Progression and Xenograft Formation in Oligodendroglial Tumors
Open the PDF for PI3K/AKT/mTOR Pathway Alterations Promote Malignant Progression and Xenograft Formation in Oligodendroglial Tumors in another window
Includes: Supplementary data
Journal Articles

Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase–mutant Glioma

Marissa Spino, Sylvia C. Kurz, Luis Chiriboga, Jonathan Serrano, Briana Zeck, Namita Sen, Seema Patel, Guomiao Shen, Varshini Vasudevaraja, Aristotelis Tsirigos, Carter M. Suryadevara, Joshua D. Frenster, Kensuke Tateishi, Hiroaki Wakimoto, Rajan Jain, Howard A. Riina, Theodore P. Nicolaides, Erik P. Sulman, Daniel P. Cahill, John G. Golfinos, Kumiko Isse, Laura R. Saunders, David Zagzag, Dimitris G. Placantonakis, Matija Snuderl, Andrew S. Chi
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (4): 1261–1271.
https://doi.org/10.1158/1078-0432.CCR-18-2312
Published: 15 February 2019
View article titled, Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase–mutant Glioma
Open the PDF for Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase–mutant Glioma in another window
Includes: Supplementary data
Journal Articles

Myc-Driven Glycolysis Is a Therapeutic Target in Glioblastoma

Kensuke Tateishi, A. John Iafrate, Quan Ho, William T. Curry, Tracy T. Batchelor, Keith T. Flaherty, Maristela L. Onozato, Nina Lelic, Sudhandra Sundaram, Daniel P. Cahill, Andrew S. Chi, Hiroaki Wakimoto
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (17): 4452–4465.
https://doi.org/10.1158/1078-0432.CCR-15-2274
Published: 31 August 2016
View article titled, Myc-Driven Glycolysis Is a Therapeutic Target in Glioblastoma
Open the PDF for Myc-Driven Glycolysis Is a Therapeutic Target in Glioblastoma in another window
Includes: Supplementary data
Journal Articles

Targetable Signaling Pathway Mutations Are Associated with Malignant Phenotype in IDH-Mutant Gliomas

Hiroaki Wakimoto, Shota Tanaka, William T. Curry, Franziska Loebel, Dan Zhao, Kensuke Tateishi, Juxiang Chen, Lindsay K. Klofas, Nina Lelic, James C. Kim, Dora Dias-Santagata, Leif W. Ellisen, Darrell R. Borger, Sarah-Maria Fendt, Matthew G. Vander Heiden, Tracy T. Batchelor, A. John Iafrate, Daniel P. Cahill, Andrew S. Chi
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (11): 2898–2909.
https://doi.org/10.1158/1078-0432.CCR-13-3052
Published: 29 May 2014
View article titled, Targetable Signaling Pathway Mutations Are Associated with Malignant Phenotype in <em>IDH</em>-Mutant Gliomas
Open the PDF for Targetable Signaling Pathway Mutations Are Associated with Malignant Phenotype in <em>IDH</em>-Mutant Gliomas in another window
Includes: Supplementary data